{"id":1255,"date":"2012-12-01T12:08:00","date_gmt":"2012-12-01T11:08:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-dezember-201"},"modified":"2022-03-17T14:12:34","modified_gmt":"2022-03-17T13:12:34","slug":"verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-dezember-201","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2012\/verordnungen-und-preise-einiger-im-amb-besprochenen-arzneimittel-basierend-auf-dem-arzneiverordnungs-report-2012-datenbasis-des-jahres-2011-gkv-arzneimittelindex-im-wido-preisstand-1-dezember-201","title":{"rendered":"Verordnungen und Preise einiger im AMB besprochenen Arzneimittel, basierend auf dem Arzneiverordnungs-Report 2012, Datenbasis des Jahres 2011: GKV-Arzneimittelindex im WIdO. Preisstand 1. Dezember 2012."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1180,129,128,131,3096,1635,1730,633,407,157,3095],"class_list":["post-1255","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-antidiabetika","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-betaxolol","tag-bisoprolol","tag-metformin","tag-metoprolol","tag-nebivolol","tag-orale-antidiabetika","tag-talinolol"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1255"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1255\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}